Pharmalittle

Pharmalittle is a daily newsletter published by STAT that provides brief summaries of the most significant news and developments in the pharmaceutical and biotechnology industries.

Why it’s in the news: It is in the news because it consistently aggregates and reports on major industry events, such as FDA decisions, clinical trial results, and corporate legal battles.

Latest on Pharmalittle

• STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
• STAT+: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and more
• STAT+: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and more
• STAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and more
• STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more
• STAT+: Pharmalittle: We’re reading about California insulin sales, a Moderna patent battle, and more

Connections

21 entities linked to Pharmalittle across the news graph.